← Leaderboards
Carolyn Louise Weeks-Levy
Hawaii Biotech, Inc.
$4,249,162
Attributed
$4,249,162
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.4M · FY2005–06$2M$1.5M$1M$500K$0
'05
'06
Funding mix
By agency
NIH$4,249,162 · 2
By mechanism
U01$3,269,254 · 1
R43$979,908 · 1
Top collaborators
No co-investigators on record.
Most similar at Hawaii Biotech, Inc.
Same institution · by research overlap
- David E. Clements$13,267,458
- Axel T Lehrer$10,832,675
- Michael M Lieberman$4,411,362
- Sherri Zimmerman Millis$1,290,247
- Alan Thomas Johnson$20,896,391
Others in their field
Top investigators on “Laboratory Mouse”
- Richard K. Wilson · Washington University$122,948,010
- Frank Patrick McCormick · University Of California San Francisco$87,382,096
- David Heimbrook · Leidos Biomedical Research, Inc.$81,904,667
- Kc Kent Lloyd · University Of California At Davis$56,148,943
- Alfred G Gilman · University Of Texas Sw Med Ctr/Dallas$53,869,943
- Carol J Bult · Jackson Laboratory$47,860,052
Research focus
Laboratory MouseDisease /Disorder ModelImmunologic Substance Development /PreparationDrug Screening /EvaluationMonoclonal AntibodyImmunomodulatorsLaboratory RabbitMacaca MulattaMicroorganism Disease ChemotherapyProtein PurificationVaccine DevelopmentVector VaccineViral VaccinesVirus AntigenBiotechnologyVirus ProteinCooperative StudyDengueDengue VirusImmunoaffinity Chromatography
Grant awards (5)
Recombinant Subunit Protein for Flu Vaccine$492,454
R43 · FY2006 · AI · contact PI
Preclinical Development of a Recombinant Dengue Vaccine$913,685
U01 · FY2005 · AI
Recombinant Subunit Protein for Flu Vaccine$487,454
R43 · FY2005 · AI
Preclinical Development of a Recombinant Dengue Vaccine$1,399,858
U01 · FY2004 · AI
Preclinical Development of a Recombinant Dengue Vaccine$955,711
U01 · FY2003 · AI